GB9122988D0
(en)
*
|
1991-10-30 |
1991-12-18 |
Ici Plc |
Heterocyclic compounds
|
GB9127279D0
(en)
*
|
1991-12-23 |
1992-02-19 |
Ici Plc |
Heterocyclic derivatives
|
GB9201749D0
(en)
*
|
1992-01-28 |
1992-03-11 |
Smithkline Beecham Plc |
Medicaments
|
US5726306A
(en)
*
|
1992-04-20 |
1998-03-10 |
Takeda Chemical Industries, Ltd. |
4,1-benzoxazepin derivatives and their use
|
GB9207961D0
(en)
*
|
1992-04-10 |
1992-05-27 |
Ici Plc |
Heterocyclic derivatives
|
JPH06508377A
(en)
*
|
1992-04-10 |
1994-09-22 |
ゼネカ リミテッド |
heterocyclic compound
|
SG82630A1
(en)
*
|
1992-04-20 |
2001-08-21 |
Takeda Chemical Industries Ltd |
4,1-benzoxazepin derivatives and their use
|
GB9211796D0
(en)
*
|
1992-06-04 |
1992-07-15 |
Ici Plc |
Heterocyclic derivatives
|
GB9216721D0
(en)
*
|
1992-08-06 |
1992-09-23 |
Ici Plc |
Therapeutic heterocyclic derivatives
|
GB9218334D0
(en)
*
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
GB9226577D0
(en)
*
|
1992-12-21 |
1993-02-17 |
Ici Plc |
Heterocyclic derivatives
|
GB9226573D0
(en)
*
|
1992-12-21 |
1993-02-17 |
Ici Plc |
Heterocyclic compounds
|
JPH08504801A
(en)
*
|
1992-12-21 |
1996-05-28 |
ゼネカ・リミテッド |
Quinuclidine derivatives as squalene synthase inhibitors
|
US5451596A
(en)
*
|
1992-12-29 |
1995-09-19 |
Rhone Poulenc Rorer Pharmaceuticals Inc. |
Cycloalkyl amine bis-aryl squalene synthase inhibitors
|
CA2115183A1
(en)
*
|
1993-02-12 |
1994-08-13 |
Takashi Nomoto |
Substituted amic acid derivatives
|
IL109451A0
(en)
*
|
1993-04-29 |
1994-07-31 |
Zeneca Ltd |
Heterocyclic derivatives
|
AU678503B2
(en)
*
|
1993-09-24 |
1997-05-29 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
|
GB9412145D0
(en)
*
|
1994-06-17 |
1994-08-10 |
Zeneca Ltd |
Heterocycles
|
US5556990A
(en)
*
|
1994-12-16 |
1996-09-17 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
|
US6297198B1
(en)
|
1996-05-14 |
2001-10-02 |
Syngenta Participations Ag |
Isoxazole derivatives and their use as herbicides
|
SE9902987D0
(en)
|
1999-08-24 |
1999-08-24 |
Astra Pharma Prod |
Novel compounds
|
DE60024651T2
(en)
|
1999-09-28 |
2006-09-28 |
Eisai Co., Ltd. |
CHINUCLIDIN COMPOUNDS AND MEDICAMENTS CONTAINING THESE AS ACTIVE ACTIVE SUBSTANCES
|
AU2001282874A1
(en)
|
2000-08-18 |
2002-03-04 |
Pharmacia And Upjohn Company |
Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
|
US6492385B2
(en)
|
2000-08-18 |
2002-12-10 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
AU2001282873A1
(en)
|
2000-08-18 |
2002-03-04 |
Pharmacia And Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
US6599916B2
(en)
|
2000-08-21 |
2003-07-29 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
US6500840B2
(en)
|
2000-08-21 |
2002-12-31 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
GB0104050D0
(en)
|
2001-02-19 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0107228D0
(en)
|
2001-03-22 |
2001-05-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2002076973A1
(en)
|
2001-03-27 |
2002-10-03 |
Eisai Co., Ltd. |
N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
|
PE20021019A1
(en)
|
2001-04-19 |
2002-11-13 |
Upjohn Co |
SUBSTITUTED AZABYCLE GROUPS
|
JP2005504058A
(en)
|
2001-08-24 |
2005-02-10 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
Substituted heteroaryl-7-aza [2.2.1] bicycloheptane for the treatment of disease
|
EP1442041A1
(en)
|
2001-11-08 |
2004-08-04 |
PHARMACIA & UPJOHN COMPANY |
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
|
SE0103818D0
(en)
|
2001-11-15 |
2001-11-15 |
Astrazeneca Ab |
Chemical compounds
|
CA2476417A1
(en)
|
2002-02-15 |
2003-08-28 |
Pharmacia & Upjohn Company |
Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
|
WO2004013137A1
(en)
|
2002-08-01 |
2004-02-12 |
Pharmacia & Upjohn Company Llc |
1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
|
GB0220581D0
(en)
|
2002-09-04 |
2002-10-09 |
Novartis Ag |
Organic Compound
|
SE0301369D0
(en)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
DE10334724A1
(en)
*
|
2003-07-30 |
2005-02-24 |
Bayer Healthcare Ag |
N-biaryl
|
US7655657B2
(en)
|
2003-12-22 |
2010-02-02 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
WO2006065233A1
(en)
*
|
2004-12-10 |
2006-06-22 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
US7160876B2
(en)
|
2003-12-22 |
2007-01-09 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
US20050245531A1
(en)
*
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
AR049401A1
(en)
|
2004-06-18 |
2006-07-26 |
Novartis Ag |
AZA-BICICLONONANS
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
GB0611907D0
(en)
|
2006-06-15 |
2006-07-26 |
Glaxo Group Ltd |
Compounds
|
US7297704B2
(en)
|
2005-02-17 |
2007-11-20 |
Wyeth |
Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
SG188307A1
(en)
|
2010-09-23 |
2013-04-30 |
Abbvie Inc |
Monohydrate of an azaadamantane derivative
|
US20170298081A1
(en)
*
|
2014-08-08 |
2017-10-19 |
Kasuma Partners Inc. |
Condensed heterocyclic compound
|
CO2018009534A2
(en)
*
|
2016-02-15 |
2018-09-20 |
Sanofi Sa |
New 6,7-dihydro-5h-benzo [7] substituted anulene compounds, processes for their preparation and therapeutic uses thereof
|
EP3541809A1
(en)
|
2016-11-17 |
2019-09-25 |
Sanofi |
Novel substituted n-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
|
EP3434272A1
(en)
|
2017-07-25 |
2019-01-30 |
Sanofi |
Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
|
MX2021002665A
(en)
|
2018-09-07 |
2021-07-16 |
Sanofi Sa |
Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoroprop yl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2- carboxylate and preparation process thereof.
|